Modern Surgery for Esophageal Cancer

Gastroenterology Clinics of North America

Volumn 37, Issue 4, 2008, Pages 965-987

  Dubecz, Attila ^a   Molena, Daniela ^a   Peters, Jeffrey H ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Esophageal cancer; Operative treatment; Review

Indexed keywords

ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; LYMPHADENECTOMY; MINIMALLY INVASIVE SURGERY; MORBIDITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PATIENT SELECTION; PHOTOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROGNOSIS; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; VAGUS NERVE;

ESOPHAGEAL NEOPLASMS; HUMANS; MIDDLE AGED;

EID: 56349138181     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2008.09.008     Document Type: Review

References (54)

1. Bedenne L., Michel P., Bouche O., et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25 10 (2007) 1160-1168
2. Pacifico R.J., Wang K.K., Wongkeesong L.M., et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 1 4 (2003) 252-257
3. Cancer statistics 2007. CA Cancer J Clin 57 (2007) 43-66
4. Oh D.S., Hagen J.A., Chandrasoma P.T., et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg. 203 2 (2006) 152-161
5. Portale G., Hagen J.A., Peters J.H., et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202 4 (2006) 588-596 [discussion 596-8]
6. Vazquez-Sequeiros E., Levy M.J., Clain J.E., et al. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc 63 2 (2006) 204-211
7. Nishimaki T., Tanaka O., Ando N., et al. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg 68 6 (1999) 2059-2064
8. Zuccaro Jr. G., Rice T.W., Vargo J.J., et al. Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol 100 3 (2005) 601-606
9. Mino-Kenudson M., Hull M.J., Brown I., et al. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc 66 4 (2007) 660-666 quiz 767, 769
10. van Vliet E.P., Heijenbrok-Kal M.H., Hunink M.G., et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98 3 (2008) 547-557
11. Rizk N., Downey R.J., Akhurst T., et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 81 3 (2006) 1076-1081
12. Swisher S.G., Erasmus J., Maish M., et al. 2-fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101 8 (2004 15) 1776-1785
13. Lordick F., Ott K., Krause B.J., et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8 9 (2007) 797-805
14. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 65 1 (2007) 3-10
15. Akiyama H., Hiyama M., and Miyazono H. Total esophageal reconstruction after extraction of the esophagus. Ann Surg 182 5 (1975) 547-552
16. Banki F., Mason R.J., DeMeester S.R., et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 236 3 (2002) 324-335 [discussion 335-6]
17. Peyre C.G., DeMeester S.R., Rizzetto C., et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg 246 4 (2007) 665-671 [discussion 671-4]
18. Jobe B.A., Kim C.Y., Minjarez R.C., et al. Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: lessons learned from the first 20 cases. Arch Surg 141 9 (2006) 857-865 [discussion 865-6]
19. Pech O., and Ell C. Is vagal-sparing esophagectomy ideal for Barrett's esophagus with intramucosal adenocarcinoma or high-grade dysplasia?. Nat Clin Pract Gastroenterol Hepatol 5 6 (2008) 302-303
20. Gemmill E.H., and McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg 94 12 (2007) 1461-1467
21. Rice T.W., Zuccaro Jr. G., Adelstein D.J., et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65 3 (1998) 787-792
22. Omloo J.M., Lagarde S.M., Hulscher J.B., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 246 6 (2007) 992-1000 [discussion 1000-1]
23. Mariette C., Piessen G., Briez N., et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247 2 (2008) 365-371
24. Greenstein A.J., Litle V.R., Swanson S.J., et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 206 2 (2008) 239-246
25. Greenstein A.J., Litle V.R., Swanson S.J., et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 112 6 (2008) 1239-1246
26. Peyre C.G. The number of lymph nodes removed predicts survival in esophageal cancer: an international study of the impact of extent of surgical resection. American Surgical Association, 128th Annual Meeting (2008)
27. Schwarz R.E., and Smith D.D. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 11 11 (2007) 1384-1393 [discussion 1393-4]
28. Schwarz R.E., and Smith D.D. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg 11 2 (2007) 158-165
29. Low D.E., Kunz S., Schembre D., et al. Esophagectomy-it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer. J Gastrointest Surg 11 11 (2007) 1395-1402 [discussion 1402]
30. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 15 (2002) 1128-1137
31. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the united states. N Engl J Med 349 22 (2003) 2117-2127
32. Orringer M.B., Marshall B., Chang A.C., et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 246 3 (2007) 363-372 [discussion 372-4]
33. Bailey S.H., Bull D.A., Harpole D.H., et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 75 1 (2003) 217-222 [discussion 222]
34. Connors R.C., Reuben B.C., Neumayer L.A., et al. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 205 6 (2007) 735-740
35. Altorki N., and Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 234 5 (2001) 581-587
36. Hagen J.A., DeMeester S.R., Peters J.H., et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234 4 (2001) 520-530 [discussion 530-1]
37. Johansson J., DeMeester T.R., Hagen J.A., et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 139 6 (2004) 627-631 [discussion 631-3]
38. Sihvo E.I., Luostarinen M.E., and Salo J.A. Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis. Am J Gastroenterol 99 3 (2004) 419-424
39. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 21 (2002) 1662-1669
40. Bollschweiler E., Baldus S.E., Schroder W., et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?. J Surg Oncol 94 5 (2006) 355-363
41. Orringer M.B., Marshall B., and Iannettoni M.D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 230 3 (1999) 392-400 [discussion 400-3]
42. Hulscher J.B., van Sandick J.W., Tijssen J.G., et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 191 2 (2000) 143-148
43. Matsubara T., Ueda M., Yanagida O., et al. How extensive should lymph node dissection be for cancer of the thoracic esophagus?. J Thorac Cardiovasc Surg 107 4 (1994) 1073-1078
44. Collard J.M., Otte J.B., Fiasse R., et al. Skeletonizing en bloc esophagectomy for cancer. Ann Surg. 234 1 (2001) 25-32
45. Swanson S.J., Batirel H.F., Bueno R., et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 72 6 (2001) 1918-1924 [discussion 1924-5]
46. Becker C.D., Barbier P.A., Terrier F., et al. Patterns of recurrence of esophageal carcinoma after transhiatal esophagectomy and gastric interposition. AJR Am J Roentgenol 148 2 (1987) 273-277
47. Gignoux M., Roussel A., Paillot B., et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11 4 (1987) 426-432
48. Nygaard K., Hagen S., Hansen H.S., et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The Second Scandinavian Trial in Esophageal Cancer. World J Surg. 16 6 (1992) 1104-1109 [discussion 1110]
49. Putnam Jr. J.B., Suell D.M., McMurtrey M.J., et al. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 57 2 (1994) 319-325
50. Horstmann O., Verreet P.R., Becker H., et al. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer. Eur J Surg 161 8 (1995) 557-567
51. Altorki N.K., Girardi L., and Skinner D.B. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg 114 6 (1997) 948-955 [discussion 955-6]
52. Orringer M.B., Marshall B., and Stirling M.C. Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg 105 2 (1993) 265-276 [discussion 276-7]
53. Rentz J., Bull D., Harpole D., et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 125 5 (2003) 1114-1120
54. Hagen J.A., Peters J.H., and DeMeester T.R. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 106 5 (1993) 850-858 [discussion 858-9]